Medicare Enrolled

Dr. Giridhar Santebennur, M.D.

Hematology & Oncology · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
247 MOREWOOD AVE, Pittsburgh, PA 15213
4126220290
Registered in NPPES since 2007
NPI: 1407976939 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Santebennur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santebennur? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Santebennur

Dr. Giridhar Santebennur is a hematology & oncology specialist in Pittsburgh, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Santebennur performed 347 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Santebennur received a total of $3,291 from 29 pharmaceutical and/or device companies across 181 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Santebennur is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 347 Medicare services $3,291 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
347
Medicare services
Bottom 28% in PA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $75 $211
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $49 $148
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
52 $112 $310
New patient office visit, complex (60-74 min) 42 $139 $460
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
27 $23 $69
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $105 $293
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
19 $136 $445
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
16 $97 $304
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
16 $62 $202
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2023 ↗
$3,291
Total received (2018-2023)
Avg $549/year across 6 years
Top 41% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
181
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$30
2022
$198
2021
$96
2020
$396
2019
$1,414
2018
$1,158

Payments by company (2023)

AstraZeneca Pharmaceuticals LP
$15
Pharmacyclics LLC, An AbbVie Company
$14
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
E.R. Squibb & Sons, L.L.C.
$534
PFIZER INC.
$388
Novartis Pharmaceuticals Corporation
$293
Pharmacyclics LLC, An AbbVie Company
$238
Takeda Pharmaceuticals U.S.A., Inc.
$195
Incyte Corporation
$186
Merck Sharp & Dohme Corporation
$134
Astellas Pharma US Inc
$109
AstraZeneca Pharmaceuticals LP
$102
SANOFI-AVENTIS U.S. LLC
$100
Myovant Sciences Inc.
$96
Bayer HealthCare Pharmaceuticals Inc.
$94
Amgen Inc.
$93
Janssen Biotech, Inc.
$91
Celgene Corporation
$90
Seagen Inc.
$89
Gilead Sciences, Inc.
$61
Verastem, Inc.
$60
TerSera Therapeutics LLC
$54
Daiichi Sankyo Inc.
$51
Genentech USA, Inc.
$50
TESARO, Inc.
$36
Karyopharm Therapeutics Inc.
$36
GlaxoSmithKline, LLC.
$36
Seattle Genetics, Inc.
$18
Lilly USA, LLC
$16
Eisai Inc.
$15
Taiho Oncology, Inc.
$14
Foundation Medicine, Inc.
$12
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Aliqopa · BOSULIF · CALQUENCE · Copiktra · DARZALEX · EMPLICITI · Enhertu · FOUNDATIONONE · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · Lonsurf · MEKINIST · NINLARO · Neulasta · OPDIVO · ORGOVYX · PADCEV · PROMACTA · Reblozyl · Revlimid · SANDOSTATIN · SPRYCEL · SUSTIVA · SUTENT · Stivarga · TASIGNA · TECENTRIQ · VELCADE · VERZENIO · XALKORI · XPOVIO · XTANDI · Xofigo · ZEJULA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Pittsburgh?
Compare hematology & oncology specialists in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
118
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
MAGEE WOMENS HOSPITAL OF UPMC HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Santebennur is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Santebennur experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Santebennur performed 97 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Santebennur receive payments from pharmaceutical companies?
Yes. Dr. Santebennur received a total of $3,291 from 29 companies across 181 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santebennur's costs compare to other hematology & oncology specialists in Pittsburgh?
Dr. Santebennur's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santebennur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →